Preclinical Imaging (In-VIVO) Market report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW) for the forecast period of 2016 to 2021. The market is expected to reach USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016 to 2021.
- Agency -.
The Preclinical Imaging (In-VIVO) Market report also studies, the factors (such as drivers, restraints, opportunities, and challenges) which affect the Preclinical Imaging (In-VIVO) Market growth in positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
Complete details on this report “Preclinical Imaging (In-VIVO) Market” spread across 161 Pages, Profiling 11 Companies and Supported with 83 Tables and 39 Figures is now available at www.rnrmarketresearch.com/preclini…arket-report.html
Market growth in global preclinical imaging market is mainly driven by factors such technological advancements in field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches.
Company Profiles Covered in this research are as follows
- Perkinelmer, Inc.
- Bruker Corporation
- Fujifilm Holdings Corporation
- Mediso Ltd.
- Milabs B.V.
- MR Solutions Ltd.
- Aspect Imaging Ltd.
- Li-Cor Biosciences
- Trifoil Imaging
- Miltenyi Biotec GmbH
These companies together accounted for a share of 63.2% of the global Preclinical Imaging (In-VIVO) Marketin 2015.
- Agency -.
New product launches and product enhancements; geographic expansions; and partnerships, agreements, and collaborations are the major strategies adopted by most of the market players to achieve growth in the preclinical imaging market.
Click Now for PDF Sample Download of this Study Report
Geographically, North America is estimated to command largest share of global Preclinical Imaging (In-VIVO) Market in 2016, followed by Europe. Large market share of the North American region can be attributed to the robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems.
Key Target Audience:
- Preclinical Imaging Instrument Manufacturers, Suppliers, and Imaging Software Providers
- Pharmaceutical and Biotechnology Companies
- Preclinical Imaging Reagent Manufacturers and Suppliers
- Contract Research Organizations (CROs)
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory Authorities
- Market Research and Consulting Service Providers
- Medical Research Laboratories
- Academic Medical Institutes and Universities
Market growth in the global Preclinical Imaging (In-VIVO) Market is mainly driven by factors such technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches. In addition, emerging markets (such as China and India) are offering new growth opportunities for preclinical imaging market players.
Connect for More Details for Information and Order “Preclinical Imaging (In-VIVO) Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global Forecast to 2021” report @ www.rnrmarketresearch.com/contacts…ount?rname=681507 .
The report studies preclinical imaging market based on modality and reagents; utilized for the assessment of anatomical, physiological, and functional parameters at molecular and cellular levels in live animal models. These imaging systems and reagents are applied to visualize living animals during preclinical research studies in order to assess the safety and efficacy of novel drug procedures or other medical treatments for human applications.
2 Preclinical Imaging Market Share Analysis, By Key Player, 2015
3 Competitive Scenario
4 New Product Launches
5 Agreements, Partnerships, and Collaborations
6 Geographical Expansions
However, continued outsourcing of in-house preclinical studies to emerging countries by U.S.-based pharmaceutical and biotechnology companies and reduced R&D expenditure by Canadian government to support research studies are negatively affecting growth of Preclinical Imaging (In-VIVO) Marketin this region.
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: